We are live on ! Find out more
CVSC

C.V. Starr & Co Portfolio holdings

AUM $192M
1-Year Est. Return 35.69%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+35.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.96M
AUM Growth
+$124K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 50.87%
2 Consumer Discretionary 49.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1
Celularity
CELU
$21.7M
$4.05M 50.87%
764,069
AMZN icon
2
Amazon
AMZN
$2.5T
$3.91M 49.13%
30,000

Similar funds

C.V. Starr & Co's Q2 2023 Portfolio in Review

As of Q2 2023, C.V. Starr & Co held 2 positions worth $7.96M, up 1.6% from $7.84M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. C.V. Starr & Co opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 60% a quarter earlier, followed by Consumer Discretionary.

  • C.V. Starr & Co's ten largest holdings make up 100% of its $7.96M portfolio in Q2 2023.
  • C.V. Starr & Co opened 0 new positions and closed 0 in Q2 2023.
  • C.V. Starr & Co's portfolio value rose 1.6% quarter-over-quarter to $7.96M.

Based on C.V. Starr & Co's 13F filing for Q2 2023, filed 14 Aug 2023.